Filing Details
- Accession Number:
- 0001209191-23-027372
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-05-04 16:50:03
- Reporting Period:
- 2023-05-02
- Accepted Time:
- 2023-05-04 16:50:03
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1242825 | M Jeffrey Leiden | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Executive Chairman | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2023-05-02 | 4,645 | $349.48 | 43,704 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-05-02 | 1,505 | $350.48 | 42,199 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-05-02 | 300 | $353.18 | 41,899 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-05-03 | 2,008 | $349.22 | 39,891 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-05-03 | 1,800 | $350.53 | 38,091 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-05-03 | 700 | $351.59 | 37,391 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 440 | Indirect | 401(k) |
Footnotes
- Transaction made pursuant to Dr. Leiden's company approved trading plan under Rule 10b5-1, which was entered into on 11/01/2022.
- Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $349.48 (range $349.00 to $349.99).
- Open market sales reported on this line occurred at a weighted average price of $350.48 (range $350.08 to $351.01).
- Open market sales reported on this line occurred at a weighted average price of $353.18 (range $352.63 to $353.53).
- Open market sales reported on this line occurred at a weighted average price of $349.22 (range $349.00 to $349.94).
- Open market sales reported on this line occurred at a weighted average price of $350.53 (range $350.08 to $350.90).
- Open market sales reported on this line occurred at a weighted average price of $351.59 (range $351.33 to $352.02).
Billionaire Hedge Funds
